$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
新型化疗药物改善了转移性乳腺癌患者的PFS
2025-10-19 11:44:20
Check Details
来那替尼纳入医保目录了吗?
2025-10-19 11:44:20
Check Details
来那替尼(Niratinib)入医保了吗?
2025-10-19 11:44:20
Check Details
Nerlynx医保后价格多少?
2025-10-19 11:44:20
Check Details
赞可达是哪里生产的?
2025-10-19 11:44:20
Check Details
FDA对口服紫杉醇(Paclitaxel)和Encequidar治疗转移性乳腺癌给予优先审查
2025-10-19 11:44:20
Check Details
在BRCA突变晚期乳腺癌患者的卡铂紫杉醇治疗中添加维利帕尼:BROCADE3xa0试验
2025-10-19 11:44:20
Check Details
阿那曲唑国内上市时间
2025-10-19 11:44:20
Check Details
阿那曲唑中国哪里有卖的?
2025-10-19 11:44:20
Check Details
阿那曲唑上市后多少钱?
2025-10-19 11:44:20
Check Details
阿那曲唑医保后的价格是多少?
2025-10-19 11:44:20
Check Details
阿那曲唑纳入医保目录了吗?
2025-10-19 11:44:20
Check Details
1
2
...
1871
1872
1873
1874
1875
1876
1877
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
2
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
3
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
4
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
5
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
6
Complete Guide to Dosage and Dose Adjustment of Entrectinib
7
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
8
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
9
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
10
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
11
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
12
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer